Literature DB >> 24222978

Evaluating the appropriate use of piperacillin/tazobactam in a community health system: a retrospective chart review.

Punit J Shah, Kristi L Ryzner.   

Abstract

Noting inappropriate uses of piperacillin/tazobactam at their institution, the authors emphasize the need for antimicrobial stewardship efforts, as well as infection-control practices, to curtail drug resistance, reduce costs, and minimize adverse events.

Entities:  

Year:  2013        PMID： 24222978      PMCID： PMC3814439     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  12 in total

1.  Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation.

Authors:  M Thuong; F Shortgen; V Zazempa; E Girou; C J Soussy; C Brun-Buisson
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

2.  Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis.

Authors:  Faranak Ansari; Kirsteen Gray; Dilip Nathwani; Gabby Phillips; Simon Ogston; Craig Ramsay; Peter Davey
Journal:  J Antimicrob Chemother       Date:  2003-10-16       Impact factor: 5.790

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

4.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

5.  Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?

Authors:  Debra A Goff; Karri A Bauer; Erica E Reed; Kurt B Stevenson; Jeremy J Taylor; Jessica E West
Journal:  Clin Infect Dis       Date:  2012-05-21       Impact factor: 9.079

6.  Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem.

Authors:  D Raveh; E Muallem-Zilcha; A Greenberg; Y Wiener-Well; Y Schlesinger; A M Yinnon
Journal:  QJM       Date:  2006-05-08

7.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

8.  Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial.

Authors:  Bernard C Camins; Mark D King; Jane B Wells; Heidi L Googe; Manish Patel; Ekaterina V Kourbatova; Henry M Blumberg
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

9.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

10.  Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa isolated from patients of lower respiratory tract infections.

Authors:  Anab Fatima; Syed Baqir Naqvi; Sheikh Abdul Khaliq; Shaheen Perveen; Sabahat Jabeen
Journal:  Springerplus       Date:  2012-12-18
View more
  5 in total

1.  Transcriptomic analysis of multi-drug resistant Escherichia coli K-12 strain in response to Lavandula angustifolia essential oil.

Authors:  Pey-Jiun Lai; Ee-Von Ng; Shun-Kai Yang; Chew-Li Moo; Wai Yee Low; Polly Soo-Xi Yap; Swee-Hua Erin Lim; Kok-Song Lai
Journal:  3 Biotech       Date:  2020-06-21       Impact factor: 2.406

2.  Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia.

Authors:  Nada A Alsaleh; Hussain A Al-Omar; Ahmed Y Mayet; Alexander B Mullen
Journal:  Saudi Pharm J       Date:  2020-09-25       Impact factor: 4.330

3.  Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.

Authors:  Andrew B Janowski; Marian G Michaels; Judith M Martin; Michael D Green
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-13       Impact factor: 3.164

4.  Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections.

Authors:  Matteo Bassetti; Javier Garau
Journal:  J Antimicrob Chemother       Date:  2021-11-22       Impact factor: 5.790

5.  Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review.

Authors:  Abdul Haseeb; Hani Saleh Faidah; Saleh Alghamdi; Amal F Alotaibi; Mahmoud Essam Elrggal; Ahmad J Mahrous; Safa S Almarzoky Abuhussain; Najla A Obaid; Manal Algethamy; Abdullmoin AlQarni; Asim A Khogeer; Zikria Saleem; Muhammad Shahid Iqbal; Sami S Ashgar; Rozan Mohammad Radwan; Alaa Mutlaq; Nayyra Fatani; Aziz Sheikh
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.